SEC Form 4 · accession 0001104659-18-073835
Inspire Medical Systems, Inc. · INSP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Timothy P. Herbert
Officer — CEO and President · Director
Period of report
Dec 18, 2018
Accepted (ET)
Dec 19, 2018 · 4:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001609550
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2,F3 | Dec 18, 2018 | S | 6,700 | $42.38 | D | 267,924 | I | By family trust |
| Common StockF4,F3 | Dec 18, 2018 | S | 7,400 | $43.18 | D | 260,524 | I | By family trust |
| Common StockF5,F3 | Dec 18, 2018 | S | 900 | $44.15 | D | 259,624 | I | By family trust |
| Common Stock | holding | — | — | — | 350 | I | By daughter |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.81 to $42.78. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3Shares held by the Timothy P. Herbert 2013 Family Irrevocable GST Trust U/A/D November 27, 2013.
- F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.81 to $43.76. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F5The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.04 to $44.27. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.